Complicated Osteoporosis in Progeroid Syndrome: Treatment With Teriparatide

被引：0
|
作者：
Iglesias Bolanos, Paloma [1 ]
Guijarro de Armas, Guadalupe [1 ]
Civantos Modino, Soraya [1 ]
Vega Pinero, Belen [1 ]
Pavon de Paz, Isabel [1 ]
Monereo Megias, Susana [1 ]
机构：
[1] Getafe Univ Hosp, Dept Endocrinol, Madrid 28007, Spain
来源：
JOURNAL OF CLINICAL DENSITOMETRY | 2012年 / 15卷 / 01期
关键词：
Fracture; osteoporosis; progeroid syndrome; teriparatide; MODEL;
D O I：
10.1016/j.jocd.2011.10.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Human progeroid syndromes (PSs) include a group of genetic "premature aging" diseases that affect a variety of organ systems. Bone diseases are common sequelae of patients diagnosed with PSs. Teriparatide therapy is recommended for elderly men with low bone mineral density (BMD; T-score < -2.5) and at least 1 fragility fracture who are unable to tolerate bisphosphonates. We describe a 20-yr-old patient affected by PS and severe osteoporosis complicated with femoral fracture. The patient experienced a significant improvement in lumbar spine BMD after treatment with teriparatide.
引用
收藏
页码：116 / 119
页数：4
相关论文
共 50 条
  • [1] Teriparatide in the treatment of osteoporosis
    Stroup, Jeffrey
    Kane, Michael P.
    Abu-Baker, Asim M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (06) : 532 - 539
  • [2] Teriparatide: Its Use in the Treatment of Osteoporosis
    Inderjeeth, Charles A.
    Chan, Kien
    Glendenning, Paul
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 67 - 80
  • [3] Indications to teriparatide treatment in patients with osteoporosis
    Rizzoli, Rene
    Kraenzlin, Marius
    Krieg, Marc-Antoine
    Mellinghoff, Hans-Ulrich
    Lamy, Olivier
    Lippuner, Kurt
    SWISS MEDICAL WEEKLY, 2011, 141
  • [4] Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide
    Pleiner-Duxneuner, Johannes
    Zwettler, Elisabeth
    Paschalis, Eleftherios
    Roschger, Paul
    Nell-Duxneuner, Valerie
    Klaushofer, Klaus
    CALCIFIED TISSUE INTERNATIONAL, 2009, 84 (03) : 159 - 170
  • [5] Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide
    Johannes Pleiner-Duxneuner
    Elisabeth Zwettler
    Eleftherios Paschalis
    Paul Roschger
    Valerie Nell-Duxneuner
    Klaus Klaushofer
    Calcified Tissue International, 2009, 84 : 159 - 170
  • [6] Teriparatide in the management of osteoporosis
    Bodenner, Donald
    Redman, Carolyn
    Riggs, Ann
    CLINICAL INTERVENTIONS IN AGING, 2007, 2 (04) : 499 - 507
  • [7] Treatment of osteoporosis with teriparatide: The Slovenian experience
    Kocjan, Tomaz
    Rajic, Antonela Sabati
    Sever, Mojca Jensterle
    Janez, Andrej
    Vidmar, Gaj
    Orehek, Nina
    Marc, Janja
    Ostanek, Barbara
    OPEN MEDICINE, 2021, 16 (01): : 1544 - 1551
  • [8] The use of teriparatide and PTH(1-84) for the treatment of osteoporosis
    Wagman R.B.
    Miller P.D.
    Clinical Reviews in Bone and Mineral Metabolism, 2006, 4 (4): : 277 - 290
  • [9] Teriparatide Treatment in Patients with Severe Osteoporosis Based on Romanian Protocol
    Carsote, Mara
    Valea, Ana
    Olaru, Maria
    Dumitrascu, Anda
    Dragomir, Adina
    Petris, Rodica
    Cocolos, Andra
    Petrova, Eugenia
    Dumitru, Nicoleta
    Ghemigian, Adina
    PROCEEDINGS OF THE 35TH BALKAN MEDICAL WEEK, 2018, : 112 - 116
  • [10] Impressive results of teriparatide treatment of postgastrectomy osteoporosis
    Bacun, Tatjana
    Kibel, Aleksandar
    Pavic, Roman
    MEDICINSKI GLASNIK, 2011, 8 (02) : 305 - 308
12345